1. Home
  2. ADPT vs VSCO Comparison

ADPT vs VSCO Comparison

Compare ADPT & VSCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADPT
  • VSCO
  • Stock Information
  • Founded
  • ADPT 2009
  • VSCO 1977
  • Country
  • ADPT United States
  • VSCO United States
  • Employees
  • ADPT N/A
  • VSCO N/A
  • Industry
  • ADPT Biotechnology: Biological Products (No Diagnostic Substances)
  • VSCO Clothing/Shoe/Accessory Stores
  • Sector
  • ADPT Health Care
  • VSCO Consumer Discretionary
  • Exchange
  • ADPT Nasdaq
  • VSCO Nasdaq
  • Market Cap
  • ADPT 1.8B
  • VSCO 1.6B
  • IPO Year
  • ADPT 2019
  • VSCO N/A
  • Fundamental
  • Price
  • ADPT $12.85
  • VSCO $26.23
  • Analyst Decision
  • ADPT Strong Buy
  • VSCO Hold
  • Analyst Count
  • ADPT 8
  • VSCO 12
  • Target Price
  • ADPT $12.38
  • VSCO $25.33
  • AVG Volume (30 Days)
  • ADPT 1.8M
  • VSCO 3.3M
  • Earning Date
  • ADPT 08-05-2025
  • VSCO 08-28-2025
  • Dividend Yield
  • ADPT N/A
  • VSCO N/A
  • EPS Growth
  • ADPT N/A
  • VSCO 6.85
  • EPS
  • ADPT N/A
  • VSCO 1.86
  • Revenue
  • ADPT $205,216,000.00
  • VSCO $6,265,451,000.00
  • Revenue This Year
  • ADPT $32.76
  • VSCO $2.39
  • Revenue Next Year
  • ADPT $15.81
  • VSCO $2.05
  • P/E Ratio
  • ADPT N/A
  • VSCO $14.12
  • Revenue Growth
  • ADPT 21.60
  • VSCO 2.29
  • 52 Week Low
  • ADPT $3.98
  • VSCO $13.76
  • 52 Week High
  • ADPT $13.52
  • VSCO $48.73
  • Technical
  • Relative Strength Index (RSI)
  • ADPT 57.00
  • VSCO 72.32
  • Support Level
  • ADPT $12.62
  • VSCO $22.02
  • Resistance Level
  • ADPT $13.25
  • VSCO $25.47
  • Average True Range (ATR)
  • ADPT 0.55
  • VSCO 1.23
  • MACD
  • ADPT -0.05
  • VSCO 0.32
  • Stochastic Oscillator
  • ADPT 58.13
  • VSCO 90.74

About ADPT Adaptive Biotechnologies Corporation

Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers, including diffuse large B-cell lymphoma (DLBCL).

About VSCO Victorias Secret & Co.

Victoria's Secret & Co is a retailer of women's intimate and other apparel and beauty products marketed under the Victoria's Secret, PINK, and Adore Me brand names. It also includes the merchandise sourcing and production function serving the Company and its international partners. The Company operates as a single segment designed to serve customers seamlessly through stores and online channels.

Share on Social Networks: